Abiopharma

🔍 Poul Mojdeh (Director)

Company: INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 848 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 848.00 | transaction_form_type: 4
• Acquired 542 shares of Common Stock (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,390.00 | transaction_form_type: 4
• Sold 848 shares of Common Stock at $13.13 per share (Direct)
  Date: 2026-01-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 542.00 | transaction_form_type: 4
• Sold 542 shares of Common Stock at $13.13 per share (Direct)
  Date: 2026-01-06 | Code: F | equity_swap_involved: 0 | transaction_form_type: 4
• Sold 848 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 102,840.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 542 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 102,298.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation.